A retrospective series of upfront therapy in primary brain lymphomas
2000-01-01 Reni, M; Ferreri, Ajm; Dell’Oro, S; Vavassori, V; Merlotti, A; Tordiglione, M; Villa, E.
COMBINATION CHEMOTHERAPY (CHT) FOLLOWED BY CHEMORADIATION FOR STAGE III PANCREATIC ADENOCARCINOMA (PA)
2008-01-01 Villa, E; Mazza, E; Passoni, P; Balzano, G; Rognone, A; Mazza, E; Nicoletti, R; Zerbi, A; Di Carlo, V; Reni, M
Resected pancreatic cancer: A proposal for a prognostic score
2005-01-01 Dell'Oro, S; Passoni, P; Balzano, G; Bonetto, E; Scaltrini, F; Zerbi, A; Staudacher, C; Villa, E; Di Carlo, V; Reni, M
First-line chemotherapy with fractionated temozolomide (bid) plus cisplatin in recurrent glioblastoma
2002-01-01 Vastola, F; Ermani, M; Paris, Mk; Basso, U; Reni, M; Et, Al
Postoperative chemotherapy for pancreatic adenocarcinoma: preliminary results with a PEFG regimen
2002-01-01 Reni, M; Passoni, P; Panucci, Mg; Balzano, G; Nicoletti, R; Bonetto, E; Schiavetto, I; Di Carlo, V; Villa, E.
Raltitrexed-eloxatin (TOM OX) salvage chemotherapy (CHT) in gemcitabine (GEM) resistant metastatic pancreatic cancer (PC): a phase II trial
2005-01-01 Reni, M; Bonetto, E; Pasetto, L; Aprile, G; Cordio, S; Passoni, P; Dell'Oro, S; Luppi, G; Milandri, C; Fugazza, C; Raffaele, Sh
Temozolomide as salvage treatment in primary central nervous system lymphomas
2006-01-01 Ferreri, A; Zaja, F; Mason, W; Perry, J; Mazza, E; Spina, M; Bordonaro, R; Faedi, M; Ilariucci, F; Reni, M
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel
2009-01-01 Cereda, S; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Nicoletti, R; Zerbi, A; Villa, E; Reni, M
Comparing conformal techniques for prostate cancer irradiation
1997-01-01 Fiorino, C; Cattaneo, Gm; Bolognesi, A; Reni, M; Calandrino, R
CLIMT-2: an ongoing phase-II trial of MATILde chemotherapy regimen (methotrexate-cytarabine-thiotepa-idarubicin) in HIV-negative primary CNS lymphomas
2002-01-01 Ferreri, Aj; Bernardi, M; Dell'Oro, S; Brandes, Aa; Reni, M; Et, Al.
Variability in contouring prostate and seminal vesicles in clinical practice: implications for conformal radiotherapy
1998-01-01 Cattaneo, Gl; Fiorino, C; Reni, M; Bolognesi, A; Calandrino, R
Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): Overall results and recursive partitioning analysis (RPA) of a phase III randomized trial of the EORTC brain tumor and radiotherapy groups and the NCIC clinical trial group
2004-01-01 Mirimanoff, R; Mason, W; Kortmann, R; Van den Bent, M; Fisher, B; Taphoorn, M; Reni, M; Curschmann, J; Villa, S; Cairncross, G; Gorlia, T; Stupp, R
Impact of 4DCT target definition on 3DCRT and IMRT planning of locally advanced pancreatic carcinoma
2007-01-01 Sangalli, G; Passoni, P; Cattaneo, Gm; Broggi, S; Esposito, D; Bettinardi, V; Reni, M; Danna, M; Mancosu, P; Fazio, F; Calandrino, R
Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer
2006-01-01 Ronzoni, M; Giordano, V; Passoni, P; Di Palo, S; Cereda, S; Reni, M; Staudacher, C; Fazio, F; Villa, E
Significant improvement of response rate and survival with cisplatin, epirubicin, 5-fluorouracil and gemcitabine (PEF-G regimen) in metastatic pancreatic cancer
1999-01-01 Reni, M; Ferreri, Ajm; Panucci, Mg; Cordio, S; Scaglietti, U; Ceresoli, Gl; Bordogna, G; Garassino, M; Villa, E
AN ITALIAN SURVEY OF METASTATIC PANCREATIC ADENOCARCINOMA
2008-01-01 Reni, M; Pasetto, Lm; Passardi, A; Milella, M; Cantore, M; Cereda, S; Aprile, G; Tronconi, Mc; Berardi, R; Falconi, M
A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer
2009-01-01 Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES
2009-01-01 Ferreri, Ajm; Reni, M; Foppoli, M; Martelli, M; Siakantaris, M; Frezzato, M; Cabras, Mg; Fabbri, A; Corazzelli, G; Ilariucci, F; Rossi, G; Soffietti, R; Stelitano, C; Vallisa, D; Zaja, F; Gelemur, M; Aondio, Gm; Avvisati, G; Balzarotti, M; Brandes, A; Costa, Mj; Gomez, H; Guarini, A; Pinotti, G; Rigacci, L; Uhlmann, C; Ponzoni, M; Zucca, E; Caligaris-Cappio, F; Cavalli, F
Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group)
2004-01-01 Brandes, Aa; Tosoni, A; Reni, M; Valduga, F; Basso, U; Lonardi, S; Pasetto, Lm; Blatt, V; Monfardini, S; Ermani, M
Extended abstract: Novel therapies against primary CNS lymphomas
2005-01-01 Ferreri, Ajm; Reni, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A retrospective series of upfront therapy in primary brain lymphomas | 1-gen-2000 | Reni, M; Ferreri, Ajm; Dell’Oro, S; Vavassori, V; Merlotti, A; Tordiglione, M; Villa, E. | |
| COMBINATION CHEMOTHERAPY (CHT) FOLLOWED BY CHEMORADIATION FOR STAGE III PANCREATIC ADENOCARCINOMA (PA) | 1-gen-2008 | Villa, E; Mazza, E; Passoni, P; Balzano, G; Rognone, A; Mazza, E; Nicoletti, R; Zerbi, A; Di Carlo, V; Reni, M | |
| Resected pancreatic cancer: A proposal for a prognostic score | 1-gen-2005 | Dell'Oro, S; Passoni, P; Balzano, G; Bonetto, E; Scaltrini, F; Zerbi, A; Staudacher, C; Villa, E; Di Carlo, V; Reni, M | |
| First-line chemotherapy with fractionated temozolomide (bid) plus cisplatin in recurrent glioblastoma | 1-gen-2002 | Vastola, F; Ermani, M; Paris, Mk; Basso, U; Reni, M; Et, Al | |
| Postoperative chemotherapy for pancreatic adenocarcinoma: preliminary results with a PEFG regimen | 1-gen-2002 | Reni, M; Passoni, P; Panucci, Mg; Balzano, G; Nicoletti, R; Bonetto, E; Schiavetto, I; Di Carlo, V; Villa, E. | |
| Raltitrexed-eloxatin (TOM OX) salvage chemotherapy (CHT) in gemcitabine (GEM) resistant metastatic pancreatic cancer (PC): a phase II trial | 1-gen-2005 | Reni, M; Bonetto, E; Pasetto, L; Aprile, G; Cordio, S; Passoni, P; Dell'Oro, S; Luppi, G; Milandri, C; Fugazza, C; Raffaele, Sh | |
| Temozolomide as salvage treatment in primary central nervous system lymphomas | 1-gen-2006 | Ferreri, A; Zaja, F; Mason, W; Perry, J; Mazza, E; Spina, M; Bordonaro, R; Faedi, M; Ilariucci, F; Reni, M | |
| A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel | 1-gen-2009 | Cereda, S; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Nicoletti, R; Zerbi, A; Villa, E; Reni, M | |
| Comparing conformal techniques for prostate cancer irradiation | 1-gen-1997 | Fiorino, C; Cattaneo, Gm; Bolognesi, A; Reni, M; Calandrino, R | |
| CLIMT-2: an ongoing phase-II trial of MATILde chemotherapy regimen (methotrexate-cytarabine-thiotepa-idarubicin) in HIV-negative primary CNS lymphomas | 1-gen-2002 | Ferreri, Aj; Bernardi, M; Dell'Oro, S; Brandes, Aa; Reni, M; Et, Al. | |
| Variability in contouring prostate and seminal vesicles in clinical practice: implications for conformal radiotherapy | 1-gen-1998 | Cattaneo, Gl; Fiorino, C; Reni, M; Bolognesi, A; Calandrino, R | |
| Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): Overall results and recursive partitioning analysis (RPA) of a phase III randomized trial of the EORTC brain tumor and radiotherapy groups and the NCIC clinical trial group | 1-gen-2004 | Mirimanoff, R; Mason, W; Kortmann, R; Van den Bent, M; Fisher, B; Taphoorn, M; Reni, M; Curschmann, J; Villa, S; Cairncross, G; Gorlia, T; Stupp, R | |
| Impact of 4DCT target definition on 3DCRT and IMRT planning of locally advanced pancreatic carcinoma | 1-gen-2007 | Sangalli, G; Passoni, P; Cattaneo, Gm; Broggi, S; Esposito, D; Bettinardi, V; Reni, M; Danna, M; Mancosu, P; Fazio, F; Calandrino, R | |
| Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer | 1-gen-2006 | Ronzoni, M; Giordano, V; Passoni, P; Di Palo, S; Cereda, S; Reni, M; Staudacher, C; Fazio, F; Villa, E | |
| Significant improvement of response rate and survival with cisplatin, epirubicin, 5-fluorouracil and gemcitabine (PEF-G regimen) in metastatic pancreatic cancer | 1-gen-1999 | Reni, M; Ferreri, Ajm; Panucci, Mg; Cordio, S; Scaglietti, U; Ceresoli, Gl; Bordogna, G; Garassino, M; Villa, E | |
| AN ITALIAN SURVEY OF METASTATIC PANCREATIC ADENOCARCINOMA | 1-gen-2008 | Reni, M; Pasetto, Lm; Passardi, A; Milella, M; Cantore, M; Cereda, S; Aprile, G; Tronconi, Mc; Berardi, R; Falconi, M | |
| A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer | 1-gen-2009 | Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E | |
| RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES | 1-gen-2009 | Ferreri, Ajm; Reni, M; Foppoli, M; Martelli, M; Siakantaris, M; Frezzato, M; Cabras, Mg; Fabbri, A; Corazzelli, G; Ilariucci, F; Rossi, G; Soffietti, R; Stelitano, C; Vallisa, D; Zaja, F; Gelemur, M; Aondio, Gm; Avvisati, G; Balzarotti, M; Brandes, A; Costa, Mj; Gomez, H; Guarini, A; Pinotti, G; Rigacci, L; Uhlmann, C; Ponzoni, M; Zucca, E; Caligaris-Cappio, F; Cavalli, F | |
| Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group) | 1-gen-2004 | Brandes, Aa; Tosoni, A; Reni, M; Valduga, F; Basso, U; Lonardi, S; Pasetto, Lm; Blatt, V; Monfardini, S; Ermani, M | |
| Extended abstract: Novel therapies against primary CNS lymphomas | 1-gen-2005 | Ferreri, Ajm; Reni, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...3021
Data di pubblicazione
- In corso di stampa1
- 2020 - 2026373
- 2010 - 2019988
- 2000 - 20091246
- 1990 - 1999399
- 1985 - 198914
Editore
- SAGE PUBLICATIONS LTD152
- LIPPINCOTT WILLIAMS & WILKINS85
- WILEY49
- ELSEVIER30
- Edizioni Minerva Medica22
- OXFORD UNIV PRESS18
- ELSEVIER SCIENCE INC15
- CELL PRESS13
- Società Italiana di Igiene, Medic...11
- BMJ PUBLISHING GROUP10
Rivista
- MULTIPLE SCLEROSIS157
- BLOOD77
- NEUROLOGY76
- INVESTIGATIVE OPHTHALMOLOGY & VIS...65
- EUROPEAN JOURNAL OF NEUROLOGY46
- ANNALS OF ONCOLOGY44
- ANNALS OF THE RHEUMATIC DISEASES27
- GASTROENTEROLOGY26
- HAEMATOLOGICA23
- MOLECULAR THERAPY21
Serie
- IFMBE PROCEEDINGS1
- INTERNATIONAL CONFERENCE ON PATTE...1
- PROCEEDINGS INTERNATIONAL SYMPOSI...1
- RADIOTHERAPY AND ONCOLOGY1
Keyword
- FA16
- ICG16
- MRI16
- OCT16
- RTA16
- SLO16
- Systemic Sclerosis14
- rehabilitation7
- ultrasound)7
- Keywords: imaging methods (CT6
Lingua
- eng1259
- ita451
- fre23
- und21
- ger1
- jpn1
- por1
Accesso al fulltext
- no fulltext2963
- reserved35
- open23